(BAA)
NYSEAMERICAN:BAABanro Corp (Banro) is a Canada-based gold mining company. The Company, through its subsidiaries, holds interest in a number of gold properties, including Twangiza, Namoya, Lugushwa and Kamituga. The Company is focused on production from the Twangiza gold mine in the Democratic Republic of the Congo (DRC). The Company's properties, totaling approximately 2,000 square kilometers, are covered by a total of over 10 exploitation permits or mining licenses. The Company, through its DRC subsidiary, Banro Congo Mining SA, holds over 10 exploration permits covering an aggregate of over 2,600 square kilometers. Approximately 10 of the exploration permits are located near its Twangiza property and approximately four are located near the Namoya property. The Twangiza property is located in the South Kivu Province of the DRC, and has an area of approximately 1,000 square kilometers. Namoya consists of prospects, including Mwendamboko, Muviringu, Kakula, Namoya Summit, Seketi and Kangurube.
Belgravia Capital International Inc,
TSE:ICPBelgravia Capital International Inc, formerly known as IC Potash Corp, is a Canada-based company focused on the provision of value-added services to the international Cannabis industry. The Company's activities include the production of specialized organic fertilizers for Cannabis plants, as well as research and development in the area of agronomics through its wholly owned subsidiary, ICP Organics Corp. Additionally, the Company is engaged in the development of blockchain technology software to support the cultivation and distribution processes, such as seed to sale tracking and quality attestation of intermediate and consumer products. The Company is also developing a royalty-streaming subsidiary.
Methode Electronics
NYSE:MEIMethode Electronics, Inc. designs, engineers, and produces mechatronic products worldwide. It operates through four segments: Automotive, Industrial, Interface, and Medical. The Automotive segment supplies electronic and electro-mechanical devices, and related products to automobile original equipment manufacturers directly or through their tiered suppliers. Its products include integrated center consoles, hidden and ergonomic switches, transmission lead-frames, complex insert molded solutions, LED-based lighting solutions, and sensors, which incorporate magneto-elastic sensing, eddy current, or other sensing technologies that monitor the operation or status of a component or system. The Industrial segment manufactures external lighting solutions comprising driving, work, and signal lights; industrial safety radio remote controls; braided flexible cables; current-carrying laminated and powder-coated busbars; high-voltage high current connector and contracts; custom power-product assemblies, such as PowerRail solution; and high-current low-voltage flexible power cabling systems that are used in aerospace, cloud computing, commercial vehicles, construction equipment, industrial, military, power conversion, and transportation markets and applications. The Interface segment provides various copper-based transceivers and related accessories for the cloud computing hardware equipment and telecommunications broadband equipment markets; user interface solutions for the appliance, commercial food service, and point-of-sale equipment markets; and fluid-level sensors for the marine/recreational vehicle and sump pump markets. The Medical segment offers Dabir Surfaces, a surface support technology aimed at pressure injury prevention for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures. Methode Electronics, Inc. was incorporated in 1946 and is headquartered in Chicago, Illinois.
Pernix Therapeutics
NASDAQ:PTXPernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.